In this near future pop-culture-filled dystopian novel, America is under the dark cloud of a new envirus, Camden-Young's Disease. Unleashed five years earlier from an explosion at a genetic engineering laboratory, the stealth envirus has laid waste to 74% of Caucasians between puberty and their early thirties while the other 26% are mysteriously immune. From flu-like attacks to excruciating fevers, hair loss, blindness, insanity and death, there is no cure; the only respite available being the Febrifuge Blue line of pharmaceuticals controlled by the Southern United Enterprises conglomerate used to treat symptoms of the target population while also used recreationally by the fortunate Sixers. Dr. Arthur Camden, dispatched from the company a year earlier by the powerful and merciless executive Trisha Lane, believes a formula for a cure (which would destroy SUE's incredibly lucrative money machine) is contained in a pair of notebooks seized when he was fired. For their return, Camden's willing to exchange four ounces of the otherwise unobtainable distillate CY6A4 he purloined just before he was dismissed that Lane craves to manufacture an experimental potion of unimaginable potential. David Stonetree, Lane's new administrative assistant, becomes the middleman between the players in this high-stakes chess match, spurred on by the fact that his partner Sharon has just been diagnosed as a CYD-positive. Torn between Lane's seductive wiles and Camden's selfless decency he finally takes a stand that could cost him his job and possibly his and Camden's lives. The story continues in Kavanagh's sequel, Weekend At Prism, with many of the characters returning in Las Vegas for the $100M World Standoff! Tournament and "the biggest rock concert ever held in the history of the Universe."